BridgeBio Soars After Drug Gets Nod in Rare Heart Condition
BridgeBio Pharma Inc.'s drug Attruby gained FDA approval to treat a rare heart disease, competing with Pfizer's medications. The drug's label claims to stabilize the misshapen transport protein linked to the disease, potentially challenging Pfizer's market dominance.